Herborium Group, Inc. (HBRM)

Herborium Announces Record Sales for Black Friday and Cyber Monday; 115% Growth over 2016

Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne, and other health and wellness concerns, announced today that its 2017 Black Friday and Cyber Monday e commerce sales for its leading dermatological product, AcnEase, grew 115% over the same sales event in 2016.

Herborium Announces 16th Quarter of Sales Growth and 4th Quarter Outlook

Herborium Group, Inc. (OTCMKTS:HBRM), a Botanical Therapeutics Company and the provider of unique all botanical medicinal products (Botanical Therapeutics) that target dermatological issues such as acne, and other health and wellness concerns, announced today its results for the 9 month period ending August 30, 2017. For the 9 month period the Company achieved revenue growth of 8% to $672,000, and gross margins increase 8.9% to $412,000.  Additionally, the Company has maintained a 61% gross profit margin. This marks the consecutive 16th quarter of continued growth.

Herborium Group, Inc. New Product Roll-out Announced. Acne Scars Product Launched for Beta Market Testing

Herborium Group, Inc. (OTCMKTS:HBRM), http://www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) announced today that it has started the roll-out of the new products by launching the topical acne scar product (www.acnease.com). This introduction of a plant cells and antigravity technology based product, Rejuvel 3D, allows Herborium to use its brand equity and increase revenues with a nominal increase of the marketing and fulfillment cost. The carefully selected addition to AcnEase Regimens speeds up collagen production and skin turnover helping to reduce acne scars, to eliminate acne marks and spots while moisturizing and rejuvenating the skin. This unique combination of benefits allows Herborium to enter into the global facial rejuvenation market that is estimated to expand from a value of US$18 Bn in 2014 to a value of US$26.5 Bn by 2021. The acne scars treatment market is expected to be worth $34.5 Billion by 2025 | Growth Rate: 9.7%. In addition as people age, acne scars often become more noticeable because our skin loses collagen so the age defying market and acne scar treatment market partially overlap allowing for more economic use of our resources. The introduction of this product will be the first of many planned collaborations with other product manufacturers to bring their products to market through our extensive distribution channels.

Herborium Group Inc., to Enter Multi-Level Marketing Space

Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne and acne scars, and other health and wellness concerns including women and men sexual health and energy deficiency has announced today that the company is planning to enter Multi Level Marketing Space also known as referral marketing and is presently in talks with two potential partners in this space. One potential partner is interested to market Herborium AcnEase Skin Management System while another well established national MLM company would focus on Herborium's Sexual Botanical Therapeutics. We will keep our shareholders abreast with the progress of this initiative.

Herborium Group Inc., to Enter Into Partnership for Asian Markets; Distribution and Additional Products Access Discussed

Herborium® Group, Inc. (OTCMKTS:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne and acne scars, and other health and wellness concerns including women and men sexual health and energy deficiency has announced today that the company is currently pursuing engagement with potential interested partners that will provide access to Asian markets for Herborium Botanical Therapeutics® while extending the Company's US natural and organic health and wellness product portfolio through additional product offering and manufacturing capabilities. The contemplated business combination has a significant value to the Company providing for a potential for multi-million dollar revenues within next 12-24 months. We will inform investors about the progress of this initiative and wherever LOI is crafted.

Revised - Herborium Group Inc., Mid-Year Shareholders Update

Herborium® Group, Inc. (OTCMKTS:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne and acne scars, and other health and wellness concerns including women and men sexual health and energy deficiency is currently engaged in the serious pursuit of new partners that will provide significant value to the Company. From co-marketing to licensing, from distribution to business combination Herborium has been involved in talks with potential partners from Canada Europe ad Asia. Specific announcements on these issues will follow soon.

Herborium Group Extends Its Historical Revenue for the First Months of 2017 and Preliminary Guidance for 3rd Quarter Is Strong

Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health concerns including women sexual health, energy depletion and male sexual health, announced today that the first half of 2017 marks the highest semi-annual six sale in the Company's history with 21% growth in revenues comparing to the same 6 months period of 2016.

Herborium Group "Lasting Pleasure" Organic, All Herbal Sexual Health Product for Woman on Fast Track for License and Distribution Agreements

Herborium Group, Inc.  (OTCMKTS:HBRM), a Botanical Therapeutics Company and the provider of unique, all botanical medicines (Botanical Therapeutics®) announced today that due to the high level of interest in its Sexual Health product , "Lasting Pleasure" is on fast track for license and distribution agreements.  

Herborium Reports 23% Increase in Sales for Second Quarter of 2017

Herborium® Group, Inc. (OTCMKTS:HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, announced  today that initial review of the Second  Quarter of 2017 shows 23% increase in Company's sales is in comparison to the same period of 2016.

Herborium Wholesale to HUT Group LLC Grows 55% in Five Months of 2017

Herborium® Group, Inc. (OTCMKTS:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicines (Botanical Therapeutics®) focused on unmet medical and wellness needs, announced today that its wholesale to HUT Group, LLC., the largest global e commerce retailer of wellness and beauty products increased  55% in the 5 months of 2017 in comparison to the same period of 2016. In addition, Herborium lead product AcnEase is designated to become a Brand of the Month on Hut Global e Commerce Platform that will further increase sale and strengthen the brand' global image.